New approaches to bacterial vaccine development:
Gespeichert in:
| Format: | Buch |
|---|---|
| Sprache: | English |
| Veröffentlicht: |
Marburg
Behringwerke AG
1997
|
| Schriftenreihe: | Behringwerke <Marburg>: Behring-Institute-Mitteilungen
98 |
| Schlagworte: | |
| Online-Zugang: | Inhaltsverzeichnis |
| Beschreibung: | 441 S. Ill., graph. Darst. |
Internformat
MARC
| LEADER | 00000nam a2200000 cb4500 | ||
|---|---|---|---|
| 001 | BV011327023 | ||
| 003 | DE-604 | ||
| 005 | 19990506 | ||
| 007 | t | ||
| 008 | 970505s1997 ad|| |||| 10||| eng d | ||
| 016 | 7 | |a 950837962 |2 DE-101 | |
| 035 | |a (OCoLC)231700120 | ||
| 035 | |a (DE-599)BVBBV011327023 | ||
| 040 | |a DE-604 |b ger |e rakddb | ||
| 041 | 0 | |a eng | |
| 049 | |a DE-355 |a DE-20 |a DE-12 |a DE-91 |a DE-188 |a DE-578 | ||
| 084 | |a MED 335f |2 stub | ||
| 084 | |a MED 460f |2 stub | ||
| 245 | 1 | 0 | |a New approaches to bacterial vaccine development |c [guest ed. of this issue: B.-U. von Specht] |
| 264 | 1 | |a Marburg |b Behringwerke AG |c 1997 | |
| 300 | |a 441 S. |b Ill., graph. Darst. | ||
| 336 | |b txt |2 rdacontent | ||
| 337 | |b n |2 rdamedia | ||
| 338 | |b nc |2 rdacarrier | ||
| 490 | 1 | |a Behringwerke <Marburg>: Behring-Institute-Mitteilungen |v 98 | |
| 650 | 0 | 7 | |a Bakterieller Impfstoff |0 (DE-588)4216344-4 |2 gnd |9 rswk-swf |
| 655 | 7 | |0 (DE-588)1071861417 |a Konferenzschrift |y 1996 |z München |2 gnd-content | |
| 689 | 0 | 0 | |a Bakterieller Impfstoff |0 (DE-588)4216344-4 |D s |
| 689 | 0 | |5 DE-604 | |
| 700 | 1 | |a Specht, Bernd-Ulrich von |e Sonstige |4 oth | |
| 830 | 0 | |a Behringwerke <Marburg>: Behring-Institute-Mitteilungen |v 98 |w (DE-604)BV002555018 |9 98 | |
| 856 | 4 | 2 | |m DNB Datenaustausch |q application/pdf |u http://bvbr.bib-bvb.de:8991/F?func=service&doc_library=BVB01&local_base=BVB01&doc_number=007610482&sequence=000001&line_number=0001&func_code=DB_RECORDS&service_type=MEDIA |3 Inhaltsverzeichnis |
| 999 | |a oai:aleph.bib-bvb.de:BVB01-007610482 | ||
Datensatz im Suchindex
| _version_ | 1804125835254300672 |
|---|---|
| adam_text | BEHRING
INSTITUTE
MITTEILUNGEN
BEHRING
INSTITUTE
RESEARCH
COMMUNICATIONS
NEW
APPROACHES
TO
BACTERIAL
VACCINE
DEVELOPMENT
NO.
98
*
FEBRUARY
1997
CONTENTS
PAGE
I.
MUCOSAL
IMMUNITY
P.
BRANDTZAEG,
A.
E.
BERSTAD,
I.
N.
FARSTAD,
G.
HARALDSEN,
L.
HELGELAND,
F.
L.
JAHNSEN,
F.-E.
JOHANSEN,
I.
B.
NATVIG,
E.
M.
NILSEN,
J.
RUGTVEIT
MUCOSAL
IMMUNITY
-
A
MAJOR
ADAPTIVE
DEFENCE
MECHANISM
1
J.-P.
KRAEHENBUHL,
S.
A.
HOPKINS,
S.
KERNEIS,
E.
PRINGAULT
ANTIGEN
SAMPLING BY
EPITHELIAL
TISSUES:
IMPLICATION
FOR
VACCINE
DESIGN
24
J.
MESTECKY,
S.
M.
MICHALEK,
Z.
MOLDOVEANU,
M.
W.
RUSSELL
ROUTES
OF
IMMUNIZATION AND
ANTIGEN
DELIVERY
SYSTEMS
FOR
OPTIMAL
MUCOSAL
IMMUNE
RESPONSES
IN
HUMANS
33
J.
L.
VANCOTT,
M.
KWEON,
K.
FUJIHASHI,
M.
YAMAMOTO,
M.
MARINARO,
H.
KIYONO,
J.
R.
MCGHEE
HELPER
T
SUBSETS
AND
CYTOKINES
FOR
MUCOSAL
IMMUNITY
AND
TOLERANCE
44
I.
STEINMETZ
COMPARATIVE
IN
VIVO
ANALYSIS
OF
IGA-
AND
IGG-MEDIATED
MUCOSAL
DEFENSE
AGAINST
BACTERIAL
PATHOGENS
53
R.
PABST,
H.
J.
ROTHKOTTER
LYMPHOCYTE
MIGRATION:
AN
ESSENTIAL
STEP
IN
UNDERSTANDING
THE
EFFECTS
OF
VACCINATION
56
PAGE
II.
NUCLEIC
ACID
IMMUNIZATION
J.
G.
MALONE,
P.
J.
BERGLAND,
P.
LILJESTROM,
G.
H.
RHODES,
R.
W.
MALONE
MUCOSAL
IMMUNE
RESPONSES
ASSOCIATED
WITH
POLYNUCLEOTIDE
VACCINATION
63
W.
F.
SWAIN,
M.
D.
MACKLIN,
V.
NEUMANN,
D.
E.
MCCABE,
R.
DRAPE,
J.
T.
FULLER,
G.
WIDERA,
M.
MCGREGOR,
R.
J.
CALLAN,
V.
HINSHAW
MANIPULATION
OF
IMMUNE
RESPONSES
VIA
PARTICLE-MEDIATED
POLYNUCLEOTIDE
VACCINES
73
J.
B.
ULMER,
R.
R.
DECK,
C
M.
DEWRRR,
J. J.
DONNELLY,
A.
FRIEDMAN,
D.
L.
MONTGOMERY,
A.
M.
YAWMAN,
I.
M.
ORME,
O.
DENIS,
J.
CONTENT,
K.
HUYGEN,
M.
A.
LIU
INDUCTION
OF
IMMUNITY
BY
DNA
VACCINATION:
APPLICATION
TO
INFLUENZA
AND
TUBERCULOSIS
79
A.
NOLL,
N.
BUCHELER,
E.
BOHN,
I.
B.
AUTENRIETH
MICROBIAL
HEAT
SHOCK
PROTEINS
AS
VACCINE
87
III.
DELIVERY
SYSTEMS
FOR
THE INDUCTION
OF
MUCOSAL
IMMUNITY
A.
LIVE
VECTORS
Z.
X.
YAN,
J.
ANDREEV,
S.
ROTTEM,
T.
F.
MEYER
CONSTRUCTION
OF
A
MYCOPLASMA
PENETRANS
EXPRESSION
LIBRARY
IN
E.
COLI
USING
THE
TWO-PHASE
EXPRESSION
SYSTEM
99
PAGE
PAGE
I.
GENTSCHEV,
G.
DIETRICH,
H.-J.
MOLLENKOPF,
Z.
SOKOLOVIC,
J.
HESS,
S.
H.
E.
KAUFMANN,
W.
GOEBEL
THE
ESCHERICHIA
COLT
HEMOLYSIN
SECRETION
APPARATUS
-
A
VERSATILE
ANTIGEN
DELIVERY
SYSTEM
IN
ATTENUATED
SALMONELLA
103
F.
SCHODEL,
D.
PETERSON,
D.
R.
MILICH,
Y.
CHAROENVIT,
J.
SADOFF,
R.
WIRTZ
IMMUNIZATION
WITH
HYBRID
HEPATITIS
B
VIRUS
CORE
PARTICLES
CARRYING
CIRCUMSPOROZOITE
ANTIGEN
EPITOPES
PROTECTS
MICE
AGAINST
PLASMODIUM
YOELII
CHALLENGE
114
M.
M.
LEVINE,
J.
GALEN,
E.
BARRY,
F.
NORIEGA,
C.
TACKET,
M.
SZTEIN,
S.
CHATFIELD,
G.
DOUGAN,
G.
LOSONSKY,
K.
KOTLOFF
ATTENUATED
SALMONELLA
TYPHI
AND
SHIGELLA
AS
LIVE
ORAL
VACCINES
AND
AS
LIVE
VECTORS
120
B.
YAKHCHALI,
P.
A.
MANNING
EPITOPE
ANALYSIS
OF
THE
CS3
FIMBRIAL
SUBUNIT
OF
HUMAN
ENTEROTOXIGENIC
ESCHERICHIA
COLI
AND
THE
CONSTRUCTION
OF
NOVEL
CS3::ST
AND
CS3::LT-B
IMMUNOGENS
124
A.
CHARBIT,
S.
M.
C.
NEWTON,
P.
E.
KLEBBA,
J.
M.
CLEMENT,
C.
FAYOLLE,
R.
LO-MAN,
C.
LECLERC,
M.
HOFNUNG
EXPRESSION
AND
IMMUNE
RESPONSE
TO
FOREIGN
EPITOPES
IN
BACTERIA.
PERSPECTIVES
FOR
LIVE VACCINE
DEVELOPMENT
135
D. W.
PASCUAL,
R.
J.
POWELL,
G.
K.
LEWIS,
D.
M.
HONE
ORAL
BACTERIAL
VACCINE
VECTORS
FOR
THE
DELIVERY
OF
SUBUNIT
AND
NUCLEIC
ACID
VACCINES
TO
THE
ORGANIZED
LYMPHOID
TISSUE
OF
THE
INTESTINE
143
P.
A.
BRETSCHER,
O.
OGUNREMI,
J.
N.
MENON
DISTINCT
IMMUNOLOGICAL
STATES
IN
MURINE
CUTANEOUS
LEISHMANIASIS
BY
IMMUNISING
WITH
DIFFERENT
AMOUNTS
OF
ANTIGEN:
THE
GENERATION
OF
BENEFICIAL,
POTENTIALLY
HARMFUL,
HARMFUL
AND
POTENTIALLY
EXTREMELY
HARMFUL
STATES
153
J.
HESS,
D.
MIKO,
I.
GENTSCHEV,
G.
DIETRICH,
W.
GOEBEL,
H.-J.
MOLLENKOPF,
C.
LADEL,
S.
H.
E.
KAUFMANN
MODULATION
OF
ANTIGEN
DISPLAY
BY
ATTENUATED
SALMONELLA
TYPHIMTTRIUM
STRAINS
AND
ITS
IMPACT
ON
PROTECTIVE
IMMUNITY
AGAINST
LISTERIOSIS
160
B.
VARIOUS
DELIVERY
SYSTEMS
T.
KISSEL,
R.
KONEBERG,
A. K.
HILBERT,
K.-D.
HUNGERER
MICROENCAPSULATION
OF
ANTIGENS
USING
BIODEGRADABLE
POLYESTERS:
FACTS
AND
PHANTASIES
172
R.
ARNON
SYNTHETIC
VACCINES
BASED
ON
PEPTIDES,
OLIGONUCLEOTIDES
AND
CONJUGATE
ANTIGENS
184
M.
P.
SZOSTAK,
H.
MADER,
M.
TRUPPE,
M.
KAMAL,
F.
O.
EKO,
V.
HUTER,
J.
MARCHART,
W.
JECHLINGER,
W.
HAIDINGER,
E.
BRAND,
E.
DENNER,
S.
RESCH,
E.
DEHLIN,
A.
KATINGER,
B.
KUEN,
A.
HASLBERGER,
A.
HENSEL,
W.
LUBITZ
BACTERIAL
GHOSTS
AS
MULTIFUNCTIONAL
VACCINE
PARTICLES
191
PAGE
PAGE
M.
SVENSSON,
J.
PFEIFER,
B.
STOCKINGER,
M.J.
WICK
BACTERIAL
ANTIGEN
DELIVERY
SYSTEMS:
PHAGOCYTIC
PROCESSING
OF
BACTERIAL
ANTIGENS
FOR
MHC-I
AND
MHC-II
PRESENTATION
TO
T
CELLS
197
A.
HENSEL,
W.
LUBITZ
VACCINATION
BY
AEROSOLS:
MODULATION
OF
CLEARANCE
MECHANISMS
IN
THE
LUNG
212
D.
H.
JONES,
C.
D.
PARTIDOS,
M. W.
STEWARD,
G.
H.
FARRAR
ORAL
DELIVERY
OF
POLY(LACTIDE-CO-
GLYCOLIDE) ENCAPSULATED
VACCINES
220
A.
D.
SMITH,
E.
ARNOLD,
G.
FERSTANDIG
ARNOLD
PROTEIN
ENGINEERING
TO
CREATE
BIOLOGICALLY
ACTIVE
PEPTIDES:
RECOMBINANT
HUMAN
RHINOVIRUSES
THAT
DISPLAY
PEPTIDE
SEQUENCES
229
H. U.
BEUSCHER,
S.
BURDACK,
M.
ROLLINGHOFF
BACTERIAL
CYTOKINE
ANTAGONISTS
ENCODED
BY
PATHOGENIC
YERSINIAE
240
IV.
VACCINATION
AGAINST
PSEUDOMONAS
AERUGINOSA
B.
TUMMLER,
J.
BOSSHAMMER,
S.
BREITENSTEIN,
I.
BROCKHAUSEN,
P.
GUDOWIUS,
C.
HERRMANN,
S.
HERRMANN,
T.
HEUER,
P.
KUBESCH,
F.
MEKUS,
U.
ROMLING,
K.
D.
SCHMIDT,
C.
SPANGENBERG,
S.
WALTER
INFECTIONS
WITH
PSEUDOMONAS
AERUGINOSA
IN
PATIENTS
WITH
CYSTIC
FIBROSIS
249
A.
BAUERNFEIND,
B.
PRZYKLENK
MICROBIOLOGICAL
BACKGROUND
FOR
ANTI-PSEUDOMONAS
AERUGINOSA
VACCINATION
IN
CYSTIC
FIBROSIS
256
A. W.
CRIPPS,
M.
L.
DUNKLEY,
R.
L.
CLANCY,
J.
KYD
VACCINE
STRATEGIES
AGAINST
PSEUDOMONAS
AERUGINOSA
INFECTION
IN
THE
LUNG
262
H.
KROGH
JOHANSEN,
S.
J.
CRYZ
JR.,
H.
P.
HOUGEN,
C.
MOSER,
N.
H0IBY
VACCINATION
PROMOTES
THL-LIKE
INFLAMMATION
AND
SURVIVAL
IN
CHRONIC
PSEUDOMONAS
AERUGINOSA
PNEUMONIA.
A
NEW
PROPHYLACTIC
PRINCIPLE
269
D.
P.
SPEERT,
S.
Y.
C.
WONG,
M.
MACDONALD,
R.
SARGEANT
MODULATION
OF
MACROPHAGE
FUNCTION
FOR
DEFENCE OF
THE
LUNG
AGAINST
PSEUDOMONAS
AERUGINOSA
274
R.
E.
W.
HANCOCK,
R.
WONG
POTENTIAL
OF
PROTEIN
OPRF
OF
PSEUDOMONAS
IN
BIVALENT VACCINES
283
H.
E.
GILLELANDJR.,
L.
B.
GILLELAND,
J.
STACZEK,
R.
N.
HARTY,
A.
GARCIA-SASTRE,
O.
G.
ENGELHARDT,
P.
PALESE
CHIMERIC
INFLUENZA
VIRUSES
INCORPORATING
EPITOPES
OF
OUTER
MEMBRANE
PROTEIN
F
AS A
VACCINE
AGAINST
PULMONARY
INFECTION
WITH
PSEUDOMONAS
AERUGINOSA
291
J.
GABELSBERGER,
B.
KNAPP,
S.
BAUERSACHS,
U.
LENZ,
B.-U.
VON
SPECHT,
H.
DOMDEY
A
HYBRID
OUTER
MEMBRANE
PROTEIN
ANTIGEN
FOR
VACCINATION
AGAINST
PSEUDOMONAS
AERUGINOSA
302
PAGE
PAGE
H.
HAHN,
P.
M.
LANE-BELL,
L.
M.
G.
GLASIER,
J.
F.
NOMELLINI,
W.
H.
BINGLE,
W.
PARANCFIYCH,
J.
SMIT
PILIN-BASED
KNU-PSEUDOMONAS
VACCINES:
LATEST
DEVELOPMENTS
AND
PERSPECTIVES
315
B.-U.
VON
SPECHT,
H.
C.
LUCKING,
B.
BLUM,
A.
SCHMITT,
K.-D.
HUNGERER,
H.
DOMDEY
THE
PSEUDOMONAS
AERUGINOSA
OUTER
MEMBRANE
PROTEIN
I
VACCINE:
IMMUNOGENICITY
AND
SAFE
ADMINISTRATION
IN
MAN
326
G.
DORING,
F.
DORNER
A
MULTICENTER
VACCINE
TRIAL
USING
THE
PSEUDOMONAS
AERUGINOSA
FLAGELLA
VACCINE
IMMUNO
IN
PATIENTS
WITH
CYSTIC
FIBROSIS
338
S.
J.
CRYZ,
JR.,
A.
LANG,
A.
RUDEBERG,
J.
WEDGWOOD,
J.
U.
QUE,
E.
FURER,
U.
SCHAAD
IMMUNIZATION
OF
CYSTIC
FIBROSIS
PATIENTS
WITH
A
PSEUDOMONAS
AERUGINOSA
O-POLYSACCHARIDE-TOXIN
A
CONJUGATE
VACCINE
345
G.
B.
PIER
RATIONALE
FOR
DEVELOPMENT
OF
IMMUNOTHERAPIES
THAT
TARGET
MUCOID
PSEUDOMONAS
AERUGINOSA
INFECTION
IN
CYSTIC
FIBROSIS
PATIENTS
350
V.
FREE
PAPER
SESSION
K.
RAUTENBERG,
C.
CICHON,
M.
A.
SCHMIDT
TOWARDS
TARGETING
STRATEGIES
FOR
ORAL
IMMUNIZATION
-
IDENTIFICATION
OF
MARKER
ANTIGENS
IN
RAT
M
CELLS
361
A.
FREY,
M.
R.
NEUTRA
TARGETING
OF
MUCOSAL
VACCINES
TO
PEYER S
PATCH
M
CELLS
376
W.
G.
BESSLER,
W.
BAIER,
U.
V.
D.
ESCHE,
P.
HOFFMANN,
L.
HEINEVETTER,
K.-H.
WIESMULLER,
G.
JUNG
BACTERIAL
LIPOPEPTIDES
CONSTITUTE
EFFICIENT
NOVEL
IMMUNOGENS
AND
ADJUVANTS
IN
PARENTERAL
AND
ORAL
IMMUNIZATION
390
H.
LANG,
T.
K.
KORHONEN
THE
OMPS
MALTOPORIN
OF
VIBRIO
CHOLERAE
AS
CARRIER
OF
FOREIGN
EPITOPES
400
A.
MEDRANO,
E.
QUEROL,
M.
DABAN
CLONING
AND
SEQUENCING
OF
THE
GENE
ENCODING
THE
OUTER-MEMBRANE
PROTEIN
TBPL
FROM
ACTINOBACILLUS
PLEUROPNEUMONIAE.
EXPRESSION
OF
TBPL
ANDTBP2
410
T.
C.
MONTIE,
D.
PHILLIPS,
WJ.LANDSPERGER
CHARACTERIZATION
OF
MONOCLONAL
ANTIBODIES
TO
PSEUDOMONAS
AERUGINOSA
TYPE
A
FLAGELLAR
ANTIGEN
424
W.
N.
BURNETTE
BACTERIAL
ADP-RIBOSYLATING
TOXINS:
FORM,
FUNCTION,
AND
RECOMBINANT
VACCINE
DEVELOPMENT
434
|
| any_adam_object | 1 |
| building | Verbundindex |
| bvnumber | BV011327023 |
| classification_tum | MED 335f MED 460f |
| ctrlnum | (OCoLC)231700120 (DE-599)BVBBV011327023 |
| discipline | Medizin |
| format | Book |
| fullrecord | <?xml version="1.0" encoding="UTF-8"?><collection xmlns="http://www.loc.gov/MARC21/slim"><record><leader>01508nam a2200361 cb4500</leader><controlfield tag="001">BV011327023</controlfield><controlfield tag="003">DE-604</controlfield><controlfield tag="005">19990506 </controlfield><controlfield tag="007">t</controlfield><controlfield tag="008">970505s1997 ad|| |||| 10||| eng d</controlfield><datafield tag="016" ind1="7" ind2=" "><subfield code="a">950837962</subfield><subfield code="2">DE-101</subfield></datafield><datafield tag="035" ind1=" " ind2=" "><subfield code="a">(OCoLC)231700120</subfield></datafield><datafield tag="035" ind1=" " ind2=" "><subfield code="a">(DE-599)BVBBV011327023</subfield></datafield><datafield tag="040" ind1=" " ind2=" "><subfield code="a">DE-604</subfield><subfield code="b">ger</subfield><subfield code="e">rakddb</subfield></datafield><datafield tag="041" ind1="0" ind2=" "><subfield code="a">eng</subfield></datafield><datafield tag="049" ind1=" " ind2=" "><subfield code="a">DE-355</subfield><subfield code="a">DE-20</subfield><subfield code="a">DE-12</subfield><subfield code="a">DE-91</subfield><subfield code="a">DE-188</subfield><subfield code="a">DE-578</subfield></datafield><datafield tag="084" ind1=" " ind2=" "><subfield code="a">MED 335f</subfield><subfield code="2">stub</subfield></datafield><datafield tag="084" ind1=" " ind2=" "><subfield code="a">MED 460f</subfield><subfield code="2">stub</subfield></datafield><datafield tag="245" ind1="1" ind2="0"><subfield code="a">New approaches to bacterial vaccine development</subfield><subfield code="c">[guest ed. of this issue: B.-U. von Specht]</subfield></datafield><datafield tag="264" ind1=" " ind2="1"><subfield code="a">Marburg</subfield><subfield code="b">Behringwerke AG</subfield><subfield code="c">1997</subfield></datafield><datafield tag="300" ind1=" " ind2=" "><subfield code="a">441 S.</subfield><subfield code="b">Ill., graph. Darst.</subfield></datafield><datafield tag="336" ind1=" " ind2=" "><subfield code="b">txt</subfield><subfield code="2">rdacontent</subfield></datafield><datafield tag="337" ind1=" " ind2=" "><subfield code="b">n</subfield><subfield code="2">rdamedia</subfield></datafield><datafield tag="338" ind1=" " ind2=" "><subfield code="b">nc</subfield><subfield code="2">rdacarrier</subfield></datafield><datafield tag="490" ind1="1" ind2=" "><subfield code="a">Behringwerke <Marburg>: Behring-Institute-Mitteilungen</subfield><subfield code="v">98</subfield></datafield><datafield tag="650" ind1="0" ind2="7"><subfield code="a">Bakterieller Impfstoff</subfield><subfield code="0">(DE-588)4216344-4</subfield><subfield code="2">gnd</subfield><subfield code="9">rswk-swf</subfield></datafield><datafield tag="655" ind1=" " ind2="7"><subfield code="0">(DE-588)1071861417</subfield><subfield code="a">Konferenzschrift</subfield><subfield code="y">1996</subfield><subfield code="z">München</subfield><subfield code="2">gnd-content</subfield></datafield><datafield tag="689" ind1="0" ind2="0"><subfield code="a">Bakterieller Impfstoff</subfield><subfield code="0">(DE-588)4216344-4</subfield><subfield code="D">s</subfield></datafield><datafield tag="689" ind1="0" ind2=" "><subfield code="5">DE-604</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Specht, Bernd-Ulrich von</subfield><subfield code="e">Sonstige</subfield><subfield code="4">oth</subfield></datafield><datafield tag="830" ind1=" " ind2="0"><subfield code="a">Behringwerke <Marburg>: Behring-Institute-Mitteilungen</subfield><subfield code="v">98</subfield><subfield code="w">(DE-604)BV002555018</subfield><subfield code="9">98</subfield></datafield><datafield tag="856" ind1="4" ind2="2"><subfield code="m">DNB Datenaustausch</subfield><subfield code="q">application/pdf</subfield><subfield code="u">http://bvbr.bib-bvb.de:8991/F?func=service&doc_library=BVB01&local_base=BVB01&doc_number=007610482&sequence=000001&line_number=0001&func_code=DB_RECORDS&service_type=MEDIA</subfield><subfield code="3">Inhaltsverzeichnis</subfield></datafield><datafield tag="999" ind1=" " ind2=" "><subfield code="a">oai:aleph.bib-bvb.de:BVB01-007610482</subfield></datafield></record></collection> |
| genre | (DE-588)1071861417 Konferenzschrift 1996 München gnd-content |
| genre_facet | Konferenzschrift 1996 München |
| id | DE-604.BV011327023 |
| illustrated | Illustrated |
| indexdate | 2024-07-09T18:07:52Z |
| institution | BVB |
| language | English |
| oai_aleph_id | oai:aleph.bib-bvb.de:BVB01-007610482 |
| oclc_num | 231700120 |
| open_access_boolean | |
| owner | DE-355 DE-BY-UBR DE-20 DE-12 DE-91 DE-BY-TUM DE-188 DE-578 |
| owner_facet | DE-355 DE-BY-UBR DE-20 DE-12 DE-91 DE-BY-TUM DE-188 DE-578 |
| physical | 441 S. Ill., graph. Darst. |
| publishDate | 1997 |
| publishDateSearch | 1997 |
| publishDateSort | 1997 |
| publisher | Behringwerke AG |
| record_format | marc |
| series | Behringwerke <Marburg>: Behring-Institute-Mitteilungen |
| series2 | Behringwerke <Marburg>: Behring-Institute-Mitteilungen |
| spelling | New approaches to bacterial vaccine development [guest ed. of this issue: B.-U. von Specht] Marburg Behringwerke AG 1997 441 S. Ill., graph. Darst. txt rdacontent n rdamedia nc rdacarrier Behringwerke <Marburg>: Behring-Institute-Mitteilungen 98 Bakterieller Impfstoff (DE-588)4216344-4 gnd rswk-swf (DE-588)1071861417 Konferenzschrift 1996 München gnd-content Bakterieller Impfstoff (DE-588)4216344-4 s DE-604 Specht, Bernd-Ulrich von Sonstige oth Behringwerke <Marburg>: Behring-Institute-Mitteilungen 98 (DE-604)BV002555018 98 DNB Datenaustausch application/pdf http://bvbr.bib-bvb.de:8991/F?func=service&doc_library=BVB01&local_base=BVB01&doc_number=007610482&sequence=000001&line_number=0001&func_code=DB_RECORDS&service_type=MEDIA Inhaltsverzeichnis |
| spellingShingle | New approaches to bacterial vaccine development Behringwerke <Marburg>: Behring-Institute-Mitteilungen Bakterieller Impfstoff (DE-588)4216344-4 gnd |
| subject_GND | (DE-588)4216344-4 (DE-588)1071861417 |
| title | New approaches to bacterial vaccine development |
| title_auth | New approaches to bacterial vaccine development |
| title_exact_search | New approaches to bacterial vaccine development |
| title_full | New approaches to bacterial vaccine development [guest ed. of this issue: B.-U. von Specht] |
| title_fullStr | New approaches to bacterial vaccine development [guest ed. of this issue: B.-U. von Specht] |
| title_full_unstemmed | New approaches to bacterial vaccine development [guest ed. of this issue: B.-U. von Specht] |
| title_short | New approaches to bacterial vaccine development |
| title_sort | new approaches to bacterial vaccine development |
| topic | Bakterieller Impfstoff (DE-588)4216344-4 gnd |
| topic_facet | Bakterieller Impfstoff Konferenzschrift 1996 München |
| url | http://bvbr.bib-bvb.de:8991/F?func=service&doc_library=BVB01&local_base=BVB01&doc_number=007610482&sequence=000001&line_number=0001&func_code=DB_RECORDS&service_type=MEDIA |
| volume_link | (DE-604)BV002555018 |
| work_keys_str_mv | AT spechtberndulrichvon newapproachestobacterialvaccinedevelopment |